$3.40
+0.01 (+0.30%)
Open$3.35
Previous Close$3.39
Day High$3.41
Day Low$3.35
52W High$5.07
52W Low$1.81
Volume—
Avg Volume29.8K
Market Cap30.42M
P/E Ratio—
EPS$-1.91
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+837.6% upside
Current
$3.40
$3.40
Target
$31.88
$31.88
$19.01
$31.88 avg
$45.37
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 177.4K | 838.5K | 5.21M |
| Net Income | -17,283,339 | -73,511,366 | -195,079 |
| Profit Margin | -9,756.5% | -9,268.7% | -3.8% |
| EBITDA | -18,822,210 | -84,504,250 | -244,954 |
| Free Cash Flow | — | — | -167,798 |
| Rev Growth | -78.8% | -78.8% | -0.3% |
| Debt/Equity | — | — | 1.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |